Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer

NCT03439033 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

273

Enrollment

OTHER

Sponsor class

Stopped Study Drug was FDA approved Summer 2021

Conditions

Prostate Cancer

Interventions

DRUG: PET/MRI with Gallium-68 labeled PSMA-HBED-CC
DRUG: Multiple PET/MRI with Gallium-68 labeled PSMA-HBED-CC
DRUG: PET/CT with Gallium-68 labeled PSMA-HBED-CC

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]